- Promote universal Lynch Syndrome screening on all newly diagnosed colorectal and endometrial cancers.
- Facilitate the ability of institutions to implement appropriate screening by sharing resources, protocols and data through network collaboration.
- Investigate universal screening for other Lynch Syndrome related malignancies.
Our Members (Click here for the 2016 Membership List)
This public membership list only includes LSSN member institutions that elected to be listed. The number of institutions that are members of LSSN are listed by state in the map below.
In September 2011, the Michigan Department of Community Health, with one-time funding from the Centers for Disease Control & Prevention (CDC) Office of Public Health Genomics, sponsored a meeting for representatives of institutions from throughout the United States who were performing or considering universal Lynch Syndrome screening on newly diagnosed colorectal cancers.
At that meeting, the 35 participants — representing the National Institutes of Health, CDC, academic medical centers, cancer facilities, and health departments — discussed the need for a network focused on universal Lynch Syndrome screening. They unanimously agreed to form the Lynch Syndrome Screening Network (LSSN) to enable ongoing cooperative efforts.
The group obtained NIH funding from the Epidemiology and Genetics Research Program to hold a follow-up LSSN meeting in 2012.
The LSSN Board of Directors
Cecelia Bellcross, PhD, MS, CGC
Deb Duquette, MS, CGC
MI Dept of Community Health
Heather Hampel, MS, CGC
Alanna Kulchak Rahm, PhD, MS, CGC
Deborah Cragun, PhD, MS, CGC
For LSSN membership information-
Questions about the LSSN website-